Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms

Etoposide-platinum (EP) chemotherapy has long been the reference treatment for grade 3 neuroendocrine neoplasms (G3 NEN). However, G3 NEN are heterogeneous, including well-differentiated tumors (NET) and poorly differentiated large (LCNEC) or small (SCNEC) cell carcinomas, whose response to EP chemo...

Full description

Bibliographic Details
Main Authors: Caroline Lacombe, Ophélie De Rycke, Anne Couvelard, Anthony Turpin, Aurélie Cazes, Olivia Hentic, Valérie Gounant, Gérard Zalcman, Philippe Ruszniewski, Jérôme Cros, Louis de Mestier
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
neuroendocrine neoplasms
chemotherapy
biomarkers
tumor response
Online Access:https://www.mdpi.com/2072-6694/13/4/643

Internet

https://www.mdpi.com/2072-6694/13/4/643

Similar Items